438 related articles for article (PubMed ID: 33223838)
1. Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis.
Yu X; Zhu L; Liu J; Xie M; Chen J; Li J
Onco Targets Ther; 2020; 13():11645-11658. PubMed ID: 33223838
[TBL] [Abstract][Full Text] [Related]
2. Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors.
Tolba MF
Int J Cancer; 2020 Dec; 147(11):2996-3006. PubMed ID: 32415713
[TBL] [Abstract][Full Text] [Related]
3. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
4. Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches.
Wang Y; Zhong X; He X; Hu Z; Huang H; Chen J; Chen K; Zhao S; Wei P; Li D
J Exp Clin Cancer Res; 2023 Jul; 42(1):177. PubMed ID: 37480104
[TBL] [Abstract][Full Text] [Related]
5. Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer.
Zhou G; Noordam L; Sprengers D; Doukas M; Boor PPC; van Beek AA; Erkens R; Mancham S; Grünhagen D; Menon AG; Lange JF; Burger PJWA; Brandt A; Galjart B; Verhoef C; Kwekkeboom J; Bruno MJ
Oncoimmunology; 2018; 7(7):e1448332. PubMed ID: 29900067
[No Abstract] [Full Text] [Related]
6. Genomics and emerging biomarkers for immunotherapy of colorectal cancer.
Kather JN; Halama N; Jaeger D
Semin Cancer Biol; 2018 Oct; 52(Pt 2):189-197. PubMed ID: 29501787
[TBL] [Abstract][Full Text] [Related]
7. Deciphering colorectal cancer immune microenvironment transcriptional landscape on single cell resolution - A role for immunotherapy.
Tieng FYF; Lee LH; Ab Mutalib NS
Front Immunol; 2022; 13():959705. PubMed ID: 36032085
[TBL] [Abstract][Full Text] [Related]
8. Emerging mechanisms progress of colorectal cancer liver metastasis.
Zhao W; Dai S; Yue L; Xu F; Gu J; Dai X; Qian X
Front Endocrinol (Lausanne); 2022; 13():1081585. PubMed ID: 36568117
[TBL] [Abstract][Full Text] [Related]
9. Application of nanotechnology in reversing therapeutic resistance and controlling metastasis of colorectal cancer.
Ren SN; Zhang ZY; Guo RJ; Wang DR; Chen FF; Chen XB; Fang XD
World J Gastroenterol; 2023 Apr; 29(13):1911-1941. PubMed ID: 37155531
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy Progress in Mismatch Repair-Deficient Colorectal Cancer and Future Therapeutic Challenges.
Link JT; Overman MJ
Cancer J; 2016; 22(3):190-5. PubMed ID: 27341597
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy in human colorectal cancer: Challenges and prospective.
Sun X; Suo J; Yan J
World J Gastroenterol; 2016 Jul; 22(28):6362-72. PubMed ID: 27605872
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in Colorectal Cancer.
Copur MS
Oncology (Williston Park); 2019 Oct; 33(10):. PubMed ID: 31661153
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy.
IJsselsteijn ME; Sanz-Pamplona R; Hermitte F; de Miranda NFCC
Mol Aspects Med; 2019 Oct; 69():123-129. PubMed ID: 31136750
[TBL] [Abstract][Full Text] [Related]
14. Review on the immunotherapy strategies against metastatic colorectal carcinoma.
Signorini L; Delbue S; Ferrante P; Bregni M
Immunotherapy; 2016 Oct; 8(10):1245-61. PubMed ID: 27605072
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?
Silveira MJ; Castro F; Oliveira MJ; Sarmento B
Biomater Sci; 2021 May; 9(9):3228-3243. PubMed ID: 33949441
[TBL] [Abstract][Full Text] [Related]
16. Perspectives on Immunotherapy of Metastatic Colorectal Cancer.
Dai Y; Zhao W; Yue L; Dai X; Rong D; Wu F; Gu J; Qian X
Front Oncol; 2021; 11():659964. PubMed ID: 34178645
[TBL] [Abstract][Full Text] [Related]
17. Results and challenges of immune checkpoint inhibitors in colorectal cancer.
Emambux S; Tachon G; Junca A; Tougeron D
Expert Opin Biol Ther; 2018 May; 18(5):561-573. PubMed ID: 29471676
[TBL] [Abstract][Full Text] [Related]
18. Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions.
Zarour LR; Anand S; Billingsley KG; Bisson WH; Cercek A; Clarke MF; Coussens LM; Gast CE; Geltzeiler CB; Hansen L; Kelley KA; Lopez CD; Rana SR; Ruhl R; Tsikitis VL; Vaccaro GM; Wong MH; Mayo SC
Cell Mol Gastroenterol Hepatol; 2017 Mar; 3(2):163-173. PubMed ID: 28275683
[TBL] [Abstract][Full Text] [Related]
19. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
Hu LF; Lan HR; Huang D; Li XM; Jin KT
Front Oncol; 2021; 11():769305. PubMed ID: 34888246
[TBL] [Abstract][Full Text] [Related]
20. The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis.
Chandra R; Karalis JD; Liu C; Murimwa GZ; Voth Park J; Heid CA; Reznik SI; Huang E; Minna JD; Brekken RA
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
